COO
The Cooper Companies, Inc
NASDAQ: COO · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$61.34
-2.77% today
Updated 2026-04-29
Market cap
$11.97B
P/E ratio
30.52
P/S ratio
2.88x
EPS (TTM)
$2.01
Dividend yield
—
52W range
$61 – $90
Volume
2.1M
The Cooper Companies, Inc (COO) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$61.34
12-Month target
$60.46
2030 Target
—
Intrinsic (DCF)
$223.83
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2027 (E) | 2028 (E) | 2029 (E) | 2030 (E) |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.9B | $3.3B | $3.6B | $3.9B | $4.1B | $4.5B | $5.0B | $5.6B | $6.2B |
| EPS | — | — | — | — | — | — | — | — | — |
CAGR applied: 10.98% (capped 20%) · P/E: 25.00x (capped 25x) · Margin: 9.67%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.